Antiplatelet therapy with aspirin, clopidogrel, and dipyridamole versus clopidogrel alone or aspirin and dipyridamole in patients with acute cerebral ischaemia (TARDIS): a randomised, open-label, phase 3 superiority trial

Antiplatelet therapy with aspirin, clopidogrel, and dipyridamole versus clopidogrel alone or aspirin and dipyridamole in patients with acute cerebral ischaemia (TARDIS): a randomised, open-label, phase 3 superiority trial

Background: Intensive antiplatelet therapy with three agents might be more effective than guideline treatment for preventing recurrent events in patients with acute cerebral ischaemia. We aimed to compare the safety and efficacy of intensive antiplatelet therapy (combined aspirin, clopidogrel, and d...

Full description

Bibliographic Details
Main Authors: Bath, Philip M.W., Woodhouse, Lisa J., Appleton, Jason P., Beridze, M., Christensen, Hanne, Dineen, Robert A., Duley, Lelia, England, Timothy J., Flaherty, Katie, Havard, Diane, Heptinstall, Stan, James, Marilyn, Krishnan, Kailash, Markus, H.S., Montgomery, Alan A., Pocock, Stuart J., Randall, Marc, Ranta, A., Robinson, Thompson G., Scutt, Polly, Venables, Graham S., Sprigg, Nikola
Format: Article
Published: Elsevier 2018
Online Access:https://eprints.nottingham.ac.uk/48990/

Internet

https://eprints.nottingham.ac.uk/48990/

Similar Items